PLX Financing Cash Flow
Protalix Biotherapeutics Inc · Financing Cash Flow
PLX Financing Cash Flow
Latest reported$296.00Kperiod ending
PLX TTM Cash from Financing ($750.00K → $296.00K)
TTM financing cash flow
High-resolution chart · PNG
PLX financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 296,000 | |
| 4,400,000 | |
| 9,326,000 | |
| 12,806,000 | |
| -7,614,000 | |
| -11,718,000 | |
| -16,794,000 | |
| -20,420,000 | |
| 0 | |
| 10,433,000 | |
| 24,666,000 | |
| 28,741,000 | |
| 30,261,000 | |
| 22,471,000 | |
| 8,238,000 | |
| 117,000 | |
| -27,393,000 | |
| -30,036,000 | |
| 12,078,000 | |
| 20,776,000 | |
| 51,238,000 | |
| 49,974,000 | |
| 46,467,000 | |
| 41,815,000 | |
| 37,343,000 | |
| 38,607,000 | |
| 0 | |
| -4,752,000 | |
| -4,752,000 | |
| -9,504,000 | |
| -9,504,000 | |
| -18,204,000 | |
| -8,662,000 | |
| -8,145,000 | |
| -14,871,000 | |
| 18,276,000 | |
| 8,734,000 | |
| 12,969,000 | |
| 19,695,000 | |
| 6,101,000 | |
| 6,101,000 | |
| 6,635,000 | |
| 6,635,000 | |
| 537,000 | |
| 549,000 | |
| 15,000 | |
| 46,000 | |
| -25,000 | |
| 66,893,000 | |
| 66,923,000 | |
| 66,892,000 | |
| 67,094,000 | |
| 24,000 | |
| 984,000 | |
| 26,558,000 | |
| 26,438,000 | |
| 26,582,000 | |
| 25,565,000 | |
| 20,927,000 | |
| 21,255,000 | |
| 21,383,000 | |
| 21,435,000 | |
| 501,000 | |
| 252,000 | |
| 312,000 | |
| 295,000 | |
| 293,000 | |
| 202,000 | |
| 10,000 | |
| -34,000 | |
| -51,000 | |
| 45,725,000 | |
| 45,642,000 | |
| 45,678,000 | |
| 58,566,000 | |
| 29,496,000 | |
| 29,579,000 | |
| 29,579,000 | |
| 16,708,000 | |
| 494,000 | |
| 494,000 | |
| 494,000 | |
| 494,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |